Primary endpoint |
 Change in PMR in the primary lesion measured by CMR imaging |
Secondary endpoint |
 Change in PMR in all lesions measured by CMR imaging  Percentage change in PMR in the primary lesion measured by CMR imaging  Percentage change in PMR in all lesion measured by CMR imaging  Changes in Hounsfield units, plaque volume, vessel area, and plaque area in the primary lesion measured by CTA  Changes in Hounsfield units, plaque volume, vessel area, and plaque area in all lesions measured by CTA  Percentage changes in Hounsfield units, plaque volume, vessel area, and plaque area in the primary lesion measured by CTA  Percentage changes in Hounsfield units, plaque volume, vessel area, and plaque area in all lesions measured by CTA |
Other endpoint |
 Changes and percentage changes in triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, non-HDL-cholesterol, VLDL-cholesterol, remnant-like cholesterol, LPL activity, and high-sensitivity C-reactive protein  Changes and percentage changes in small, dense LDL and mean LDL particle diameter  Changes and percentage changes in EPA, DHA, AA, EPA/AA ratio, and omega-3 index (weight percentage of eicosapentaenoic acid [EPA, C20:5ω3] and docosahexaenoic acid [DHA, C20:6ω3] in total fatty acids out of all lipids)  Changes and percentage changes in leptin and adiponectin |